A Medicina Biomolecular foi regulamentada pelo Conselho Federal de Medicina na Resolução 1500/1998 e homologada na Resolução 1938/2010 com a assessoria da Associação Brasileira de Medicina Biomolecular.
 

Carnosina possui atividade anti isquêmica cerebral e cardíaca: diminui a mortalidade e melhora as condições clínicas dos animais

 

                                 

            04/03/2010


Anti-ischemic activity of carnosine.

Stvolinsky SL, Dobrota D. Biochemistry (Mosc). 2000 Jul;65(7):849-55.

Laboratory of Clinical Neurochemistry, Institute of Neurology, Russian Academy of Medical Sciences, Moscow, 123367 Russia. sls@bio.inevro.msk.ru.
This review summarizes the data on anti-ischemic activity of carnosine. The pronounced anti-ischemic effects of carnosine in the brain and heart are due to the combination of antioxidant and membrane-protecting activity, proton buffering capacity, formation of complexes with transition metals, and regulation of macrophage function. In experimental cerebral ischemia, carnosine decreases mortality and is beneficial for neurological conditions of the animals. In cardiac ischemia, carnosine protects cardiomyocytes from damage and improves contractility of the heart. The data indicate that carnosine can be used as an anti-ischemic drug.
PMID: 10951104

 


   

 

 

 

© 2004 Associação Brasileira de Medicina Complementar. Todos os Direitos Reservados Rua Conde de Porto Alegre , 1985 - Campo Belo
São Paulo - SP - CEP: 04608-003
Tel.: 11-5093-5685